Back to mobile site

Haemonetics (HAE) Misses Q1 EPS by 3c

August 1, 2016 8:30 AM EDT

Haemonetics (NYSE: HAE) reported Q1 EPS of $0.25, $0.03 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $210 million versus the consensus estimate of $205.41 million.

For earnings history and earnings-related data on Haemonetics (HAE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings